Persist AI
About Persist AI
Persist AI develops an automation and machine learning platform that accelerates the formulation discovery process for drug manufacturers and CROs by 30-50%. Their technology utilizes high-throughput robotic labs and AI-driven predictions to streamline the development of extended-release PLG drug formulations, significantly reducing the time and cost associated with traditional methods.
```xml <problem> Traditional drug formulation discovery for extended-release PLG drugs is a time-consuming and expensive process, often taking years and requiring extensive manual experimentation. This lengthy process delays the availability of new medications and increases development costs for pharmaceutical companies and CROs. </problem> <solution> Persist AI offers an automation and machine learning platform that accelerates formulation discovery by integrating high-throughput robotic labs with AI-driven predictions. The platform enables rapid screening of thousands of formulations in parallel, using online analytical tests and onboard sensors to gather comprehensive data. This data is then fed into proprietary AI algorithms that predict optimal formulations and generate protocols for the robotic lab, significantly reducing the time and cost associated with traditional methods. The platform supports both solid and liquid formulations, offering a complete solution for formulation development. </solution> <features> - High-throughput robotic lab capable of running thousands of formulations in parallel - Integrated online analytical tests, including HPLC, spectrophotometry, and Raman spectroscopy - Onboard sensors for comprehensive formulation analysis - AI platform for analyzing complex formulation data sets and predicting optimal formulations - Automated mixing using homogenization, sonication, and other techniques - Capabilities for both solid and liquid formulations, including evaporation and lyophilization - Process automation to minimize human errors and ensure reproducibility - Cloud Lab interface allowing scientists to remotely design and monitor experiments </features> <target_audience> The primary target audience includes drug manufacturers and contract research organizations (CROs) involved in the development of extended-release PLG drug formulations. </target_audience> ```
What does Persist AI do?
Persist AI develops an automation and machine learning platform that accelerates the formulation discovery process for drug manufacturers and CROs by 30-50%. Their technology utilizes high-throughput robotic labs and AI-driven predictions to streamline the development of extended-release PLG drug formulations, significantly reducing the time and cost associated with traditional methods.
Where is Persist AI located?
Persist AI is based in Woodland, United States.
When was Persist AI founded?
Persist AI was founded in 2022.
How much funding has Persist AI raised?
Persist AI has raised 4500000.
Who founded Persist AI?
Persist AI was founded by Karthik Raman.
- Karthik Raman - CEO
- Location
- Woodland, United States
- Founded
- 2022
- Funding
- 4500000
- Employees
- 27 employees
- Major Investors
- Y Combinator, Pioneer Fund, Fellows Fund, Innospark Ventures, 2048 Ventures